Drug Approval | August 28, 2023
Briefs: Granules India
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Eris Lifesciences enters into term loan agreement with Citi Bank
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
The medical device sector is considered as one of the sunrise sectors in the country
Subscribe To Our Newsletter & Stay Updated
